FOSAPREPITANT DIMEGLUMINE 150 mg/5mL

Fosaprepitant dimeglumine 150 mg/5mL is a lyophilized powder for intravenous solution, used to prevent nausea and vomiting. This medication is commonly administered in clinical settings for chemotherapy-induced nausea and vomiting (CINV).

Fosaprepitant dimeglumine is primarily used to prevent nausea and vomiting caused by chemotherapy. It works by blocking substances in the body that can trigger these symptoms. This medication is often used in combination with other antiemetics to enhance its effectiveness. Patients undergoing chemotherapy may be prescribed fosaprepitant dimeglumine to manage CINV.

Common effects of fosaprepitant dimeglumine may include fatigue, headache, and diarrhea. Some patients may also experience constipation or dizziness. These effects are generally mild and temporary, but severe or persistent symptoms should be discussed with a healthcare provider.

Fosaprepitant dimeglumine should be handled with care, following proper procedures for intravenous administration. It is important to use this medication exactly as prescribed and to inform healthcare providers of any allergies or medical conditions. Proper storage and handling are essential to maintain the medication's efficacy.

Fosaprepitant dimeglumine may interact with other medications, including those metabolized by the liver's cytochrome P450 enzymes. It is important to inform healthcare providers of all medications being taken to avoid potential interactions. Alcohol and certain supplements may also affect the medication's effectiveness.